| Panel | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
|
| Panel | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||
|
| Panel | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
Update yourself on the latest news and read Stem Cell Matters, our monthly newsletter.
|
| Panel | ||||||||
|---|---|---|---|---|---|---|---|---|
| ||||||||
Read the most important updates from the WMDA office and notifications to support global collaboration. 14 March, 2024 Click here to register for the upcoming committee meeting of the Registry Operations and Regulation Committee on Tuesday, 19 March from 13:00 - 14:00 CET. Find more details here. Information for Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) - Establishments Regarding FDA's Determination that Zika Virus is no Longer a Relevant Communicable Disease Agent or Disease On the morning of May 21, 2024, the FDA announced that Zika Virus is no longer a relevant communicable disease agent or disease for HCT/Ps. As such, screening for risk of Zika Virus will no longer be required for cord blood donors, cord blood banking, or for manufacturing of cellular therapies derived from cord blood or birthing tissues. Travel to areas of the world where Zika Virus previously occurred will no longer be an exclusion for cord blood banking or for cord blood licensure. The change went into effect yesterday, May 20, 2024. Find here more information, click here. ----------------------------------------------------------------------------------------------------------------------------------- November 27, 2023 Information from Karelian BMD Registry (ION 8256) a) performed in Russia if courier can deliver the donor’s product from Russia to the transplant center; b) performed outside Russia if courier is unable to deliver the donor’s product from Russia to the transplant center. * In each case the decision is made jointly with the requesting registry taking into account the specific situation. Contacts for requesting centers: e-mail: karelianbmd.donation@yahoo.com; katelian.bmd@onego.ru tel: +7 905 299 91 8; fax: +7 8142 765 897 -------------------------------------------------------------------------- REDOME Survey Please help the Brazilian Bone Marrow Donor Registry, REDOME, by filling out their survey: here. ------------------------------------------------------------------------------------------------------------------------- WMDA strongly condemns the violence that is occurring in Ukraine, Israel and Gaza. We offer our sympathies to all those who are suffering because of this conflictthese conflicts. We extend our support to the donor registries and medical centres whose donors and patients are negatively affected by this crisisthese crises. ------------------------------------------------------------------------------------------------------------------------- |
| Panel | ||||||
|---|---|---|---|---|---|---|
| ||||||
